DK2900279T3 - Grpr-antagonister til detektering, diagnose og behandling af grpr-positiv cancer - Google Patents
Grpr-antagonister til detektering, diagnose og behandling af grpr-positiv cancerInfo
- Publication number
- DK2900279T3 DK2900279T3 DK13815181.6T DK13815181T DK2900279T3 DK 2900279 T3 DK2900279 T3 DK 2900279T3 DK 13815181 T DK13815181 T DK 13815181T DK 2900279 T3 DK2900279 T3 DK 2900279T3
- Authority
- DK
- Denmark
- Prior art keywords
- grpr
- diagnosis
- detection
- treatment
- antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/008—Peptides; Proteins
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261705513P | 2012-09-25 | 2012-09-25 | |
| PCT/US2013/061712 WO2014052471A1 (en) | 2012-09-25 | 2013-09-25 | Grpr-antagonists for detection, diagnosis and treatment of grpr-positive cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2900279T3 true DK2900279T3 (da) | 2019-09-30 |
Family
ID=49887190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13815181.6T DK2900279T3 (da) | 2012-09-25 | 2013-09-25 | Grpr-antagonister til detektering, diagnose og behandling af grpr-positiv cancer |
Country Status (19)
| Country | Link |
|---|---|
| US (6) | US9839703B2 (da) |
| EP (2) | EP2900279B1 (da) |
| JP (4) | JP6562838B2 (da) |
| KR (2) | KR102190005B1 (da) |
| AU (4) | AU2013323596C1 (da) |
| BR (1) | BR112015006453B1 (da) |
| CA (2) | CA2886068C (da) |
| DK (1) | DK2900279T3 (da) |
| ES (1) | ES2745635T3 (da) |
| HR (1) | HRP20191620T1 (da) |
| HU (1) | HUE045724T2 (da) |
| IL (3) | IL237844B (da) |
| LT (1) | LT2900279T (da) |
| MX (1) | MX362675B (da) |
| PL (1) | PL2900279T3 (da) |
| PT (1) | PT2900279T (da) |
| RU (2) | RU2019119378A (da) |
| SI (1) | SI2900279T1 (da) |
| WO (1) | WO2014052471A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013007660A1 (en) * | 2011-07-08 | 2013-01-17 | Biosynthema Inc. | Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors |
| PT2900279T (pt) * | 2012-09-25 | 2019-10-14 | Advanced Accelerator Applications Usa Inc | Antagonistas de grpr para a deteção, diagnóstico e tratamento de cancro positivo para grpr |
| EP3015462A1 (en) * | 2014-10-29 | 2016-05-04 | OctreoPharm Schiences GmbH | Enantiopure chelating agents for chelator coupled pharmaceuticals, corresponding preparation method thereof and chelator coupled pharmaceuticals |
| EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
| WO2018048882A1 (en) | 2016-09-06 | 2018-03-15 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
| JP7034160B2 (ja) | 2016-11-28 | 2022-03-11 | バイエル・ファルマ・アクティエンゲゼルシャフト | 磁気共鳴画像法に使用するための高緩和度ガドリニウムキレート化合物 |
| PT3568205T (pt) | 2017-01-12 | 2023-10-26 | Radiomedix Inc | Tratamento de células de cancro que sobrexpressam recetores de somatostatina com a utilização de derivados de ocreótido quelado a radioisótopos |
| CN113195005B (zh) * | 2018-10-12 | 2023-07-21 | 国际先进加速器应用公司 | 包含放射性标记的grpr拮抗剂和表面活性剂的药物组合物 |
| WO2021068051A1 (en) * | 2018-11-13 | 2021-04-15 | Provincial Health Services Authority | Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders |
| US11944690B2 (en) | 2018-11-23 | 2024-04-02 | Bayer Aktiengesellschaft | Formulation of contrast media and process of preparation thereof |
| JP2022548875A (ja) * | 2019-09-16 | 2022-11-22 | ノバルティス アーゲー | 安定した濃縮放射性医薬組成物 |
| TW202123975A (zh) * | 2019-09-17 | 2021-07-01 | 義大利商先進艾斯雷特應用（義大利）公司 | 放射性標記grpr拮抗劑之方法及其套組 |
| AU2020356262A1 (en) * | 2019-09-24 | 2022-05-05 | Novartis Ag | Radiolabelled GRPR-antagonist for use as theragnostic |
| AU2020405585A1 (en) * | 2019-12-19 | 2022-08-11 | Technische Universität München | Modified GRPR antagonist peptides for imaging and therapy of cancer |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5019647A (en) * | 1988-05-24 | 1991-05-28 | Merck & Co., Inc. | Gastrin releasing peptide antagonist |
| US4943561A (en) | 1988-11-28 | 1990-07-24 | Merck & Co., Inc. | Gastrin releasing peptide antagonist |
| US5028692A (en) * | 1989-04-25 | 1991-07-02 | Merck & Co., Inc. | Gastrin releasing peptide antagonist |
| JPH04502629A (ja) | 1989-11-06 | 1992-05-14 | フアルミタリア・カルロ・エルバ・エツセ・エルレ・エルレ | 還元不可逆性ボンベシンアンタゴニスト |
| JPH07505865A (ja) | 1992-02-07 | 1995-06-29 | メレルダウファーマスーティカルズ インコーポレイテッド | ボンベシンのフェニルアラニン類似体類 |
| US5620955A (en) | 1993-06-18 | 1997-04-15 | Peptide Technologies Corporation | Bombesin receptor antagonists and uses thereof |
| EP1033372A4 (en) | 1997-11-18 | 2000-10-04 | Chugai Pharmaceutical Co Ltd | COMPOSITIONS WITH ANTI-TUMOR ACTIVITY |
| CA2783275A1 (en) * | 2003-07-24 | 2005-02-03 | Bracco Imaging S.P.A. | Stable radiopharmaceutical compositions and methods for their preparation |
| EP2100900A1 (en) * | 2008-03-07 | 2009-09-16 | Universitätsspital Basel | Bombesin analog peptide antagonist conjugates |
| KR20140053819A (ko) | 2010-11-22 | 2014-05-08 | 피라말 이미징 에스에이 | 방사선요법용 177루테튬-표지 봄베신 유사체 |
| WO2013007660A1 (en) * | 2011-07-08 | 2013-01-17 | Biosynthema Inc. | Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors |
| PT2900279T (pt) * | 2012-09-25 | 2019-10-14 | Advanced Accelerator Applications Usa Inc | Antagonistas de grpr para a deteção, diagnóstico e tratamento de cancro positivo para grpr |
-
2013
- 2013-09-25 PT PT138151816T patent/PT2900279T/pt unknown
- 2013-09-25 LT LT13815181T patent/LT2900279T/lt unknown
- 2013-09-25 BR BR112015006453-1A patent/BR112015006453B1/pt active IP Right Grant
- 2013-09-25 JP JP2015534625A patent/JP6562838B2/ja active Active
- 2013-09-25 US US14/431,096 patent/US9839703B2/en active Active
- 2013-09-25 SI SI201331585T patent/SI2900279T1/sl unknown
- 2013-09-25 ES ES13815181T patent/ES2745635T3/es active Active
- 2013-09-25 DK DK13815181.6T patent/DK2900279T3/da active
- 2013-09-25 RU RU2019119378A patent/RU2019119378A/ru unknown
- 2013-09-25 PL PL13815181T patent/PL2900279T3/pl unknown
- 2013-09-25 CA CA2886068A patent/CA2886068C/en active Active
- 2013-09-25 RU RU2015115529A patent/RU2693465C9/ru active
- 2013-09-25 HU HUE13815181A patent/HUE045724T2/hu unknown
- 2013-09-25 WO PCT/US2013/061712 patent/WO2014052471A1/en active Application Filing
- 2013-09-25 EP EP13815181.6A patent/EP2900279B1/en active Active
- 2013-09-25 KR KR1020157007572A patent/KR102190005B1/ko active IP Right Grant
- 2013-09-25 CA CA3114832A patent/CA3114832A1/en active Pending
- 2013-09-25 AU AU2013323596A patent/AU2013323596C1/en active Active
- 2013-09-25 EP EP19170067.3A patent/EP3536347A1/en active Pending
- 2013-09-25 KR KR1020207034970A patent/KR102314293B1/ko active IP Right Grant
- 2013-09-25 MX MX2015003772A patent/MX362675B/es active IP Right Grant
-
2015
- 2015-03-19 IL IL237844A patent/IL237844B/en active IP Right Review Request
-
2017
- 2017-11-20 US US15/817,776 patent/US20180133349A1/en not_active Abandoned
- 2017-12-28 IL IL256649A patent/IL256649B/en active IP Right Grant
-
2018
- 2018-06-21 AU AU2018204513A patent/AU2018204513C1/en active Active
-
2019
- 2019-06-04 JP JP2019104379A patent/JP6997135B2/ja active Active
- 2019-08-16 AU AU2019216714A patent/AU2019216714B2/en active Active
- 2019-09-09 HR HRP20191620 patent/HRP20191620T1/hr unknown
- 2019-09-24 US US16/580,990 patent/US11083805B2/en active Active
-
2020
- 2020-07-26 IL IL276300A patent/IL276300A/en unknown
-
2021
- 2021-03-26 AU AU2021201914A patent/AU2021201914A1/en active Pending
- 2021-07-23 US US17/383,577 patent/US20210346529A1/en active Pending
- 2021-07-23 US US17/383,550 patent/US20210346528A1/en active Pending
- 2021-07-23 US US17/383,567 patent/US20220008568A1/en active Pending
- 2021-09-22 JP JP2021154188A patent/JP7358430B2/ja active Active
-
2023
- 2023-07-13 JP JP2023115231A patent/JP2023126440A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2900279T3 (da) | Grpr-antagonister til detektering, diagnose og behandling af grpr-positiv cancer | |
| HK1214112A1 (zh) | 非侵入式血液分析 | |
| EP2973282A4 (en) | DETECTION AND ANALYSIS OF FRAUD | |
| BR112015003320A2 (pt) | aparelhos e métodos eletrocirúrgicos. | |
| BR112014027465A2 (pt) | teste de imunosseleção de multiplex. | |
| DK2743669T3 (da) | Fejldetekteringssystem og tilhørende fremgangsmåde | |
| BR112015002958A2 (pt) | aparelho de posicionamento de paciente articulado. | |
| DK2854883T3 (da) | Biomatrix-hydrogeler og fremgangsmåder til anvendelse deraf | |
| BR112015019495A2 (pt) | aparelho de tratamento de vestuário. | |
| EP2807479A4 (en) | DEVICES AND METHODS FOR RAPIDLY AND PRECISELY DETECTING THE SUBSTANCES TO BE ANALYZED | |
| EP2902830A4 (en) | FOCUS DETECTION DEVICE AND IMAGING DEVICE | |
| BR112014031335A2 (pt) | bloco de diagnóstico transacional | |
| BR112014029372A2 (pt) | medição do corpo | |
| BR112014033075A2 (pt) | dispositivo de gaxeta, e, turbomáquina. | |
| GB2534406B (en) | Fault detection and diagnosis | |
| BR112014028916A2 (pt) | dispositivo urológico implantável com recurso de recuperação. | |
| BR112014027937A2 (pt) | estação de imagem corporal total e dispositivo de imagem corporal total. | |
| BR112015024856A2 (pt) | métodos de determinação ou de monitoramento | |
| BR112014028640A2 (pt) | sistema de monitoramento portátil de pacientes configurável | |
| FI20126266A (fi) | Pehmopaperin mittaus | |
| HK1206960A1 (en) | Apparatuses for detecting and or diagnosing swallowing disorders | |
| BR112017000271A2 (pt) | chip de sensor eletroquímico | |
| GB2510701B (en) | Improved malware detection | |
| CO7091176A2 (es) | Diagnóstico farmacéutico | |
| DK2844988T3 (da) | Elektrokemisk detektionsfremgangsmåde |